angiotensin ii has been researched along with Insulin Resistance in 211 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 24 (11.37) | 18.2507 |
| 2000's | 104 (49.29) | 29.6817 |
| 2010's | 81 (38.39) | 24.3611 |
| 2020's | 2 (0.95) | 2.80 |
| Authors | Studies |
|---|---|
| Bandinelli, M; Boddi, M; Chiostri, M; Coppo, M; Modesti, PA; Poggesi, L | 1 |
| Leng, J; Li, J; Li, X; Liu, J; Lu, Q; Ren, D; Rousselle, T; Sun, X | 1 |
| Boylston, J; Casin, KM; Fillmore, N; Kohr, MJ; Liu, C; Ma, H; Murphy, E; Noguchi, A; Sinha, P; Sun, J; Wang, N; Zhou, G | 1 |
| Chen, X; Deng, B; Feng, J; Wang, L | 1 |
| Jang, HC; Kim, KM; Kong, SH; Lee, DH; Lee, JE; Lim, S; Min, SH; Oh, TJ; Park, KS | 1 |
| Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V | 1 |
| Kasacka, I; Nowińska, P | 1 |
| Chan, CB; Son, M; Wu, J | 1 |
| Azushima, K; Haku, S; Haruhara, K; Imajo, K; Ishigami, T; Kato, I; Kinguchi, S; Kishio, N; Kobayashi, R; Minegishi, S; Nakajima, A; Ohashi, K; Ohki, K; Tamura, K; Toya, Y; Uneda, K; Wakui, H; Yamada, T; Yamaji, T; Yamashita, A | 1 |
| Chen, XM; Huang, MJ; Li, P; Su, TY; Wang, Y; Wei, RB; Yang, Y | 1 |
| Attrill, E; Keske, MA; Kim, J; Premilovac, D; Rattigan, S; Richards, SM | 1 |
| Graus-Nunes, F; Souza-Mello, V | 1 |
| AlSiraj, Y; Cassis, LA; Chen, J; Shoemaker, R | 1 |
| Américo, ALV; Evangelista, FS; Fonseca-Alaniz, MH; Martucci, LF; Muller, CR; Vecchiatto, B | 1 |
| Nistala, R; Whaley-Connell, A | 1 |
| Arefi, S; Mottaghi, S; Sharifi, AM | 1 |
| Chhabra, KH; Lazartigues, E; Pedersen, KB; Speth, RC; Xia, H | 1 |
| Andreozzi, F; Carnevale, D; Casaburo, M; Hribal, ML; Perticone, F; Perticone, M; Presta, I; Sciacqua, A; Sesti, G; Tassone, EJ | 1 |
| D'Aquino, K; Feener, EP; King, GL; Li, Q; Maeda, Y; Mima, A; Mizutani, K; Park, K; Rask-Madsen, C; White, MF; Winnay, J | 1 |
| Chen, JR; Wu, LY; Yang, HY; Yeh, WJ | 1 |
| Carranza, A; Dominici, FP; Fernández, BE; Giani, JF; Höcht, C; Mayer, MA; Muñoz, MC; Puyó, AM; Taira, CA | 1 |
| Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Sumi, T; Tanaka, T; Tsurumi, H | 1 |
| Lopaschuk, GD; Mori, J; Oudit, GY; Zhang, L | 1 |
| Härdtner, C; Lendeckel, U; Mörke, C; Walther, R; Wolke, C | 1 |
| Del Valle-Mondragón, L; Echeverría-Rodríguez, O; Hong, E | 1 |
| Burghi, V; Dominici, FP; Giani, JF; Muñoz, MC | 1 |
| MacLeod, KM; McNeill, JH; Tran, LT | 2 |
| Calò, LA; Davis, PA; Rossi, GP | 1 |
| Ding, L; Feng, XM; Gao, Q; Sun, HJ; Tang, CS; Zhou, H; Zhou, YB; Zhu, GQ | 1 |
| Carlström, M; Fredholm, BB; Gao, X; Harris, RA; Hezel, M; Jansson, L; Lai, EY; Liu, M; Peleli, M; Persson, AE; Sandberg, M; Yang, T; Zhang, XM; Zollbrecht, C | 1 |
| El-Bassossy, HM; Watson, ML | 1 |
| Bader, M; Barkhausen, J; Raasch, W; Santos, RA; Schuchard, J; Schuster, F; Stölting, I; Thorns, C; Vogt, FM; Winkler, M | 1 |
| Liu, C; Nishiyama, A; Raij, L; Tian, R; Zhou, MS | 1 |
| Benigni, A; Buelli, S; Cassis, P; Longaretti, L; Macconi, D; Morigi, M; Perico, L; Perico, N; Remuzzi, G | 1 |
| Beneit, N; Benito, M; Díaz-Castroverde, S; Escribano, Ó; Gómez-Hernández, A; Otero, YF; Perdomo, L | 1 |
| Adler, GK; Fitch, KV; Grinspoon, SK; Lo, J; Mayhew, C; Srinivasa, S; Stanley, T; Torriani, M; Wong, K | 1 |
| Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V; Pandey, A | 1 |
| Al-Salami, H; Elahy, M; Lam, V; Mamo, JC; Mooranian, A; Negrulj, R; Takechi, R | 1 |
| Campbell, KH; Choi, I; Corr, SA; Fisher, PA; Gardner, DS; Gutierrez, CG; Lee, JH; Rathbone, AJ; Sinclair, KD | 1 |
| Amara, VR; Dhawale, VS; Pamulapati, H; Sharma, E; Tikoo, K | 1 |
| Bando, YK; Ito, S; Matsuura, N; Murohara, T; Nagasawa, K; Nagata, K; Sano, Y; Uchinaka, A; Yamada, Y; Yoneda, M | 1 |
| Chen, J; Lin, SY; Long, Q; Ni, L; Yin, Y; You, L; Zhang, JY; Zhang, Q | 1 |
| Krskova, K; Slamkova, M; Zorad, S | 1 |
| Burghi, V; Cervino, IA; Dominici, FP; Mazziotta, L; Miquet, JG; Muñoz, MC; Quiroga, DT | 1 |
| Carreón-Torres, E; Del Valle-Mondragón, L; Díaz-Díaz, E; Guarner-Lans, V; Ibarra-Lara, L; Rubio-Ruiz, ME; Sánchez-Aguilar, M; Sánchez-Mendoza, A; Soria-Castro, E; Vázquez-Meza, H | 1 |
| Bupha-Intr, T; Prasannarong, M; Saengsirisuwan, V; Surapongchai, J | 1 |
| Lee, JH; Palaia, T; Ragolia, L | 1 |
| Lastra-González, G; Lastra-Lastra, G; Manrique-Acevedo, C; Restrepo-Erazo, K; Sowers, JR | 1 |
| Arellano-Plancarte, A; Castillo-Hernandez, JR; Olivares-Reyes, JA | 1 |
| Raij, L; Schulman, IH; Zhou, MS | 1 |
| Gao, L; Mann, GE | 1 |
| Ferrario, C; Habibi, J; Hayden, MR; Lastra, G; Manrique, C; Patel, K; Rehmer, J; Sowers, JR; Whaley-Connell, AT | 1 |
| Chu, KY; Leung, PS | 1 |
| Ke, L; Lu, ZM; Yu, YR; Zhang, XE; Zhang, XX | 1 |
| Endo, K; Koide, N; Miyashita, Y; Murano, T; Ohira, M; Oyama, T; Saiki, A; Shirai, K; Watanabe, H | 1 |
| Horiuchi, M; Iwai, M | 1 |
| Gardner, M; Lastra, G; Manrique, C; Sowers, JR | 1 |
| Brillante, DG; Brillante, RE; Howes, LG; O'Sullivan, AJ | 1 |
| Fujisawa, Y; Hitomi, H; Hosomi, N; Ichihara, A; Ito, H; Kimura, S; Kiyomoto, H; Kohno, M; Nagai, Y; Nakano, D; Nishiyama, A; Pelisch, N | 1 |
| Cassis, LA; Charnigo, R; Daugherty, A; Police, SB; Thatcher, SE | 1 |
| Elmarakby, AA; Imig, JD | 1 |
| Arellano-Plancarte, A; Catt, KJ; Hernandez-Aranda, J; Olivares-Reyes, JA | 1 |
| Arranz, C; Dominici, FP; Giani, JF; Mayer, MA; Muñoz, MC; Taira, CA; Toblli, JE; Turyn, D; Veiras, LC | 1 |
| Adler, GK; Garg, R; Hopkins, PN; Hurwitz, S; Williams, GH | 1 |
| Rizvi, AA | 1 |
| Bodineau, L; Hus-Citharel, A; Llorens-Cortes, C | 1 |
| de Leeuw, PW; Houben, AJ; Jonk, AM; Schaper, NC; Serné, EH; Smulders, YM; Stehouwer, CD | 1 |
| Brooks, VL; Dampney, RA; Heesch, CM | 1 |
| Cao, W; Ko, SH; Liu, Z | 1 |
| Ecelbarger, CM; Jose, PA; Li, F; Wang, X | 1 |
| Adler, GK; Brown, NJ; Garg, R; Hopkins, PN; Hurwitz, S; Williams, GH | 1 |
| Chrousos, GP; Katsilambros, N; Kouskouni, E; Margeli, A; Mastorakos, G; Papassotiriou, I; Pavlatou, MG; Tentolouris, N | 1 |
| Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Salvadeo, SA; Santoro, T; Zoppi, A | 1 |
| Aavula, BR; Anandan, SK; Cases, S; Chen, D; Cheng, Y; Do, ZN; Gless, R; Hammock, BD; Jones, PD; MacIntyre, DE; Mehra, U; Patel, DV; Sabry, J; Tran, V; Vincelette, J; Wang, YX; Waszczuk, J; Webb, HK; Whitcomb, R; White, K; Wong, KR; Zhang, LN | 1 |
| Bizzarri, A; Blaak, EE; Cajlakovic, M; Clément, K; Cleutjens, JP; Essers, Y; Goossens, GH; Jocken, JW; Konings, E; Ribitsch, V; Venteclef, N | 1 |
| Fujita, Y; Hara, T; Hitomi, H; Kaifu, K; Kiyomoto, H; Kobori, H; Kohno, M; Moriwaki, K; Nakano, D; Nishiyama, A; Sofue, T | 1 |
| Griendling, KK; Hitomi, H; Lassègue, B; Mehta, PK; San Martin, A; Seidel-Rogol, B; Taniyama, Y | 1 |
| Kamata, K; Kobayashi, T; Matsumoto, T; Nemoto, S; Taguchi, K | 1 |
| Fukui, A; Hara, M; Murozono, Y; Nagano-Torigoe, Y; Nakagawa, M; Ooie, T; Saikawa, T; Shinohara, T; Takahashi, N; Taniguchi, Y; Teshima, Y; Thuc, LC; Wakisaka, O; Yoshimatsu, H; Yufu, K | 1 |
| Furuhashi, M; Koyama, M; Maeda, T; Miura, T; Shimamoto, K; Tanaka, M; Togashi, N; Yoshida, H | 1 |
| Itoh, H; Sasamura, H | 1 |
| Li, H; Wang, A; Wang, G; Zhang, Y; Zhu, X | 1 |
| Abdulla, MH; Abdullah, NA; Johns, EJ; Sattar, MA | 1 |
| Horiuchi, M; Jing, F; Mogi, M | 1 |
| Dong, X; Liu, D; Sun, J; Xiao, X; Zhang, F; Zhang, X | 1 |
| Burghi, V; Carranza, A; Dominici, FP; Giani, JF; Mayer, MA; Muñoz, MC; Taira, CA | 1 |
| Henriksen, EJ; Prasannarong, M | 1 |
| Fletcher, JA; Matthew Morris, E; Rector, RS; Thyfault, JP | 1 |
| Masaki, T; Mori, H; Nishiyama, A; Rafiq, K | 1 |
| Muniyappa, R; Yavuz, S | 1 |
| Kusumoto, K | 1 |
| Hanasaki-Yamamoto, H; Hongyo, K; Kamide, K; Kawai, T; Oguro, R; Ohishi, M; Rakugi, H; Sugimoto, K; Takami, Y; Takeda, M; Takemura, Y; Takeshita, H; Takeya, Y; Tatara, Y; Yamamoto, K | 1 |
| Henriksen, EJ; Prasannarong, M; Santos, FR | 1 |
| Araki, E; Motoshima, H | 1 |
| Adler, GK; Underwood, PC | 1 |
| Fukahori, M; Hidaka, S; Inoue, N; Kawahara, S; Maruyama, M; Miura, N; Muguruma, M; Ohta, K; Yamada, K | 1 |
| Alrob, OA; Harris, RA; Lopaschuk, GD; Mori, J; Oudit, GY; Wagg, CS | 1 |
| Hattori, Y; Jesmin, S; Kitabatake, A; Mowa, CN; Sakuma, I | 1 |
| Engeli, S; Gorzelniak, K; Janke, J; Luft, FC; Sharma, AM | 1 |
| Aburatani, H; Anai, M; Ando, K; Asano, T; Chiba, Y; Fujishiro, M; Fujita, T; Fukushima, Y; Katagiri, H; Kikuchi, M; Komuro, I; Noguchi, N; Ogihara, T; Onishi, Y; Ono, H; Sakoda, H; Shojima, N | 1 |
| Fukuda, N; Izumi, Y; Jian, T; Kanmatsuse, K; Nakayama, M; Nakayama, T; Satoh, C; Soma, M | 1 |
| Ailhaud, G; Boschmann, M; Engeli, S; Gorzelniak, K; Janke, J; Massiéra, F; Schling, P; Sharma, AM; Teboul, M | 1 |
| Barton, M; Carmona, R; Krieger, JE; Ortmann, J; Traupe, T | 1 |
| Cleland, SJ; Connell, JM; Gould, GW; Morton, IJ; Palmer, T; Perry, CG; Petrie, JR; Salt, IP | 1 |
| Asano, T; Fujita, T; Ogihara, T | 1 |
| Kumar, A; McFarlane, SI; Sowers, JR | 1 |
| Moskowitz, DW | 1 |
| Asano, T; Ogihara, T | 1 |
| Ando, K | 2 |
| Hattori, Y; Jesmin, S; Kitabatake, A; Sakuma, I | 1 |
| Calegari, VC; Carvalheira, JB; Franchini, KG; Guimarães, RB; Nadruz, W; Ribeiro, EB; Saad, MJ; Velloso, LA; Zecchin, HG | 1 |
| Ayajiki, K; Kashiwagi, A; Nishio, Y; Okamura, T; Shinozaki, K; Sugaya, T | 1 |
| Frohlich, ED; Sowers, JR | 1 |
| Sowers, JR | 1 |
| Jabs, K; Kon, V | 1 |
| Ando, K; Asano, T; Fujita, T; Itakura, K; Matsui, H; Ogihara, T; Qingyou, X; Shimosawa, T; Xing, G | 1 |
| Vollenweider, P | 1 |
| Baritono, E; Calò, L; Ceolotto, G; Ciccariello, L; Iori, E; Papparella, I; Pessina, AC; Sartori, M; Semplicini, A | 1 |
| Iwasaka, T; Okigaki, M | 1 |
| Barinas-Mitchell, E; Cottam, DR; Eid, G; Kelley, DE; Kuller, L; Mattar, SG; Schauer, PR | 1 |
| Adachi, M; Hirano, T; Ran, J | 1 |
| Baritono, E; Calò, L; Ceolotto, G; Ciccariello, L; Leoni, M; Papparella, I; Sartori, M; Semplicini, A | 1 |
| Fulton, D; Marrero, MB; Stepp, D; Stern, DM | 1 |
| Dong, J; Fujii, S; Furumoto, T; Goto, D; Imagawa, S; Kitabatake, A; Mishima, T; Nakai, Y; Sobel, BE; Zaman, AK | 1 |
| Halliwill, JR; Jensen, MD; Joyner, MJ; Nielsen, S | 1 |
| Bahtyiar, G; Blendea, MC; Ferrario, CM; Jacobs, D; Kumar, P; McFarlane, SI; Ogrin, C; Sha, Q; Sowers, JR; Stas, S; Stump, CS | 1 |
| Leiter, LA; Lewanczuk, RZ | 1 |
| Chang, CL; Chien, Y; Ho, LT; Ho, PH; Juan, CC; Kwok, CF; Lai, YH; Wu, LY; Yang, WM | 1 |
| Bloch-Faure, M; Even, P; Ferre, P; Guerre-Millo, M; Moustaid-Moussa, N; Quignard-Boulange, A; Yvan-Charvet, L | 1 |
| Ali, N; Ebina, Y; Fujita, Y; Ishizawa, K; Izawa, Y; Kanematsu, Y; Obata, T; Tamaki, T; Tomita, S; Tsuchiya, K; Yoshizumi, M | 1 |
| Clasen, R; Clemenz, M; Foryst-Ludwig, A; Kintscher, U; Krikov, M; Schupp, M; Sprang, C; Thöne-Reineke, C; Unger, T | 1 |
| Nagaria, AM; Reddy, S; Savin, VJ; Sharma, M; Sharma, R; Wiegmann, TB | 1 |
| Diehl, CJ; Henriksen, EJ; Kim, JS; Saengsirisuwan, V; Sloniger, JA | 1 |
| Kaul, CL; Ramarao, P; Srinivasan, K; Viswanad, B | 1 |
| Avogaro, A; Calò, LA; Davis, PA; Pagnin, E; Semplicini, A | 1 |
| Calò, LA; Ceolotto, G; Lenzini, L; Leoni, M; Papparella, I; Sartori, M; Semplicini, A | 1 |
| Horiuchi, M; Iwai, M; Mogi, M | 1 |
| Adachi, M; Fukui, T; Hirano, T; Kageyama, H; Okada, K; Ran, J; Saito, K | 1 |
| Dell'Oro, R; Grassi, G; Mancia, G; Quarti-Trevano, F; Scopelliti, F | 1 |
| Kawasaki, H; Kurosaki, Y; Mio, M; Takatori, S; Zamami, Y | 1 |
| Burnier, M; Cefai, D; Maillard, M; Nussberger, J; Perregaux, C; Zanchi, A | 1 |
| Chen, Y; Cunha, TS; Elased, KM; Farah, V; Irigoyen, MC; Key, MP; Morris, M | 1 |
| Argentino, DP; Dominici, FP; Muñoz, MC; Toblli, JE; Turyn, D | 1 |
| Fukuda, N | 1 |
| Blaak, EE; Goossens, GH; Saris, WH; Schiffers, PM; van Baak, MA | 1 |
| Castle, SM; Daley, BJ; Enderson, BL; Karlstad, MD; Kasper, SO | 1 |
| Fujita, T | 1 |
| Vinson, GP | 1 |
| Leung, PS | 1 |
| Gaikwad, AB; Ramarao, P; Viswanad, B | 1 |
| Ayajiki, K; Kashiwagi, A; Masada, M; Nishio, Y; Okamura, T; Shinozaki, K; Yoshida, Y | 1 |
| Elased, KM; Farah, V; Morris, M | 1 |
| Goralski, KB; Sinal, CJ | 1 |
| Carvalheira, JB; Carvalho-Filho, MA; Saad, MJ; Velloso, LA | 1 |
| Henriksen, EJ | 1 |
| Cooper, SA; Habibi, J; Lastra, G; Manrique, C; Sowers, JR; Stas, S; Wei, Y; Whaley-Connell, A | 1 |
| Fujita, Y; Hara, T; Hitomi, H; Ihara, G; Kaifu, K; Kiyomoto, H; Kohno, M; Moriwaki, K; Nishiyama, A; Ugawa, T | 1 |
| Brillante, DG; Howes, LG; Johnstone, MT; O'Sullivan, AJ | 1 |
| Huang, Y; Lau, CW; Leung, FP; Lin, SG; Wong, WT; Yu, XY; Yung, LM; Zhong, JC | 1 |
| Boesen, EI; Hair, CD; Mintz, JD; Pollock, DM; Stepp, DW; Sullivan, JC | 1 |
| Miura, T; Shimamoto, K | 1 |
| Adler, GK; Bentley-Lewis, R; Garg, R; Hopkins, PN; Perlstein, T; Seely, EW; Williams, GH | 1 |
| Chen, XY; Du, GT; Ji, H; Li, YQ; Meng, ZK; Shi, WB; Tian, J; Zhang, YH | 1 |
| Boyle, PJ | 1 |
| Hamamoto, A; Harada, N; Masori, M; Mawatari, K; Nakaya, Y; Takahasi, A | 1 |
| Huang, XZ; Li, XH; Lin, QX; Lin, SG; Xiao, DZ; Yu, XY; Zhong, JC | 1 |
| Alfarano, C; Cerbai, E; Mannucci, E; Mugelli, A; Nediani, C; Raimondi, L; Sartiani, L | 1 |
| Clark, SE; Ferrario, CM; Li, W; Sowers, JR; Stump, CS; Wei, Y | 1 |
| Liu, Z | 1 |
| Egawa, T; Hanafusa, N; Kawasaki, H; Mio, M; Takatori, S; Yabumae, N; Zamami, Y | 1 |
| Davis, SN; Perkins, JM | 1 |
| Mitsuyama, K | 1 |
| Jong, CJ; Ricci, C; Schaffer, SW | 1 |
| Ueda, S | 1 |
| Abel, ED; Buchanan, J; Cooksey, RC; Tabbi-Anneni, I | 1 |
| Cachofeiro, V; Lahera, V; Maeso, R; Navarro-Cid, J; Perez-Vizcaino, F; Ruilope, LM; Tamargo, J | 1 |
| Higashiura, K; Hirata, A; Iimura, O; Masuda, A; Matsuda, K; Miyazaki, Y; Nakagawa, M; Shimamoto, K; Takizawa, H; Ura, N | 1 |
| Arnold, U; Fliser, D; Fode, P; Kohl, B; Nowicki, M; Ritz, E | 1 |
| Rao, RH | 1 |
| Gaboury, CL; Hollenberg, NK; Seely, EW; Simonson, DC; Williams, GH | 1 |
| Abel, MA; Zemel, MB | 1 |
| Antonipillai, I; Bergman, R; Buchanan, T; Nadler, JL; Natarajan, R; Rude, R | 1 |
| Eide, IK; Høieggen, A; Kjeldsen, SE; Moan, A; Nordby, G | 1 |
| Donnely, R; Morris, AD | 1 |
| Attvall, S; Herlitz, H; Persson, B; Urbanavicius, V; Widgren, B | 1 |
| Fickova, M; Kral, JG; Macho, L; Zelezna, B; Zorad, S | 1 |
| Iyer, SN; Katovich, MJ | 2 |
| Arzilli, F; Ferrannini, E; Frascerra, S; Natali, A; Pecori, N; Quiñones Galvan, A; Salvetti, A; Taddei, S | 1 |
| Schiffrin, EL; Touyz, RM | 1 |
| Liu, H; Wang, J | 1 |
| Brocco, S; Bruttomesso, D; Del Prato, S; Girardi, C; Jori, E; Mazzon, C; Pianta, A; Semplicini, A; Tiengo, A; Trevisan, R; Vedovato, M | 1 |
| Corradi, L; Fogari, R; Lazzari, P; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Dumont, AS; McNeill, JH; Verma, S | 1 |
| Guan, B; Guo, D; Ji, B; Pang, L; Sun, M | 1 |
| Ader, M; Bergman, RN; Moore, D; Richey, JM | 1 |
| Schiffrin, EL | 1 |
| Cassis, LA | 1 |
| Dumont, AS; McNeill, JH; Verma, S; Yao, L | 1 |
| Donnelly, R; Gray, S; Idris, I; Patiag, D; Qu, X; Seale, JP; Wilkes, M | 1 |
| Blüher, M; Kratzsch, J; Paschke, R | 1 |
| Katovich, MJ; Pachori, A | 1 |
| Baritono, E; Ceolotto, G; Iori, E; Monari, A; Reato, S; Semplicini, A; Trevisan, R; Valente, R | 1 |
| Fogari, E; Fogari, R; Malamani, G; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Andersen, UB; Dige-Petersen, H; Ibsen, H; Rokkedal, J; Steensgaard-Hansen, F | 1 |
| Chikara, S; Fukuda, N; Hu, WY; Kanmatsuse, K; Kishioka, H; Nakayama, M; Teng, J | 1 |
| Peuler, JD; Simpson, L; Sowers, JR; Zemel, MB | 1 |
| DiPette, DJ; Nickols, GA; Nickols, M; Townsend, RR; Yamamoto, R | 1 |
| Bilo, HJ; Donker, AJ; Gans, RO; Heine, RJ; Nauta, JJ; von Maarschalkerweerd, WW | 1 |
59 review(s) available for angiotensin ii and Insulin Resistance
| Article | Year |
|---|---|
AMPK: a balancer of the renin-angiotensin system.
Topics: AMP-Activated Protein Kinases; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Autophagy; Blood Pressure; Blood Vessels; Gene Expression Regulation; Humans; Insulin Resistance; Kidney; Muscle, Skeletal; Myocardium; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction | 2019 |
Changes in the pancreas caused by different types of hypertension.
Topics: Angiotensin II; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; Pancreas | 2017 |
The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Delivery Systems; Homeostasis; Humans; Insulin Resistance; Islets of Langerhans; Peptide Fragments; Renin-Angiotensin System | 2019 |
Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.
Topics: Albuminuria; Angiotensin II; Animals; Cardio-Renal Syndrome; Humans; Insulin Resistance; Kidney Glomerulus; Metabolic Syndrome; Signal Transduction | 2013 |
Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
Topics: Angiopoietins; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Carbohydrate Metabolism; Energy Metabolism; Fatty Acids; Heart; Heart Failure; Humans; Insulin Resistance; Mitochondria; Myocardium; Oxidation-Reduction; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System | 2013 |
Modulation of the action of insulin by angiotensin-(1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2014 |
Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism.
Topics: Angiotensin II; Bartter Syndrome; Gitelman Syndrome; Glucose; GTP-Binding Proteins; Humans; Hypertension; Insulin Resistance; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2014 |
Alternative renin-angiotensin system pathways in adipose tissue and their role in the pathogenesis of obesity.
Topics: Adipose Tissue; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Prorenin Receptor; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2016 |
Role of aldosterone and angiotensin II in insulin resistance: an update.
Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Humans; Insulin Resistance; Metabolic Diseases; Renin-Angiotensin System | 2009 |
Angiotensin II and the development of insulin resistance: implications for diabetes.
Topics: Angiotensin II; Diabetes Mellitus; Humans; Insulin Resistance; Renin-Angiotensin System | 2009 |
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
Topics: Angiotensin II; Animals; Antioxidants; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Enzyme Activation; Glycation End Products, Advanced; Humans; Insulin Resistance; Mitochondria; NADPH Oxidases; NF-E2-Related Factor 2; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxidative Stress; Protein Kinase C; Reactive Oxygen Species; Signal Transduction | 2009 |
Angiotensin II in type 2 diabetes mellitus.
Topics: Angiotensin II; Animals; Diabetes Mellitus, Type 2; Humans; Insulin Resistance | 2009 |
Role of renin-angiotensin system in adipose tissue dysfunction.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Animals; Cell Differentiation; Humans; Insulin Resistance; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2009 |
The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.
Topics: Angiotensin II; Endothelium; Humans; Hypertension; Insulin Resistance; Kidney; Oxidative Stress; Renin-Angiotensin System; Risk Factors; Sodium; Sympathetic Nervous System | 2009 |
Pregnancy and the endocrine regulation of the baroreceptor reflex.
Topics: Angiotensin II; Animals; Baroreflex; Blood Pressure; Cardiovascular System; Endocrine System; Female; Heart Rate; Humans; Hydroxyprogesterones; Insulin; Insulin Resistance; Medulla Oblongata; Neural Pathways; Nitric Oxide; Pregnancy; Pregnancy Complications; Prosencephalon; Sympathetic Nervous System | 2010 |
Hypertension management and microvascular insulin resistance in diabetes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Diabetes Mellitus, Type 2; Humans; Hypertension; Inflammation; Insulin Resistance; Microcirculation; Microvessels; Nitric Oxide Synthase Type III; Oxidative Stress; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction | 2010 |
Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Mineralocorticoid; Renin-Angiotensin System; Signal Transduction | 2013 |
Increased cord blood angiotensin II concentration is associated with decreased insulin sensitivity in the offspring of mothers with gestational diabetes mellitus.
Topics: Angiotensin II; Birth Weight; Blood Glucose; Diabetes, Gestational; Female; Fetal Blood; Glucose Tolerance Test; Homeostasis; Humans; Infant; Infant, Newborn; Insulin; Insulin Resistance; Male; Maternal-Fetal Exchange; Metabolic Syndrome; Pregnancy; Reference Values; Risk Factors | 2013 |
The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport, Active; Diabetes Mellitus, Type 2; Glucose; Humans; Insulin Resistance; Insulin-Secreting Cells; Muscle, Skeletal; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2013 |
The role of angiotensin II in nonalcoholic steatohepatitis.
Topics: Angiotensin II; Animals; Chronic Disease; Fatty Liver; Humans; Insulin Resistance; Liver Cirrhosis; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Renin-Angiotensin System; Signal Transduction | 2013 |
(Pro)renin receptor and insulin resistance: possible roles of angiotensin II-dependent and -independent pathways.
Topics: Angiotensin II; Animals; Glucose Intolerance; Humans; Insulin Resistance; Muscle, Skeletal; Oligopeptides; Proton-Translocating ATPases; Rats; Rats, Inbred OLETF; Receptors, Cell Surface; Signal Transduction; Vacuolar Proton-Translocating ATPases | 2013 |
Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act.
Topics: Angiotensin II; Animals; Blood Flow Velocity; Capillaries; Endothelium, Vascular; Humans; Insulin; Insulin Resistance; MAP Kinase Signaling System; Muscle, Skeletal; Nitric Oxide; Phosphatidylinositol 3-Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Vasoconstriction; Vasodilation | 2013 |
[In vitro and in vivo pharmacological profiles of a novel angiotensin type 1-receptor blocker, azilsartan].
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypertension; Insulin Resistance; Obesity; Oxadiazoles | 2012 |
[RAAS and insulin resistance].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Oxidative Stress; Renin-Angiotensin System | 2012 |
The renin angiotensin aldosterone system and insulin resistance in humans.
Topics: Adipose Tissue; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Blood Pressure; Glucose; Hemodynamics; Humans; Insulin Resistance; Models, Animal; Muscle, Skeletal; Obesity; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2013 |
The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?
Topics: Adipocytes; Adipose Tissue, Brown; Angiotensin II; Angiotensinogen; Animals; Humans; Hypertension; Insulin Resistance; Metabolic Syndrome; Mice; Obesity; Peptidyl-Dipeptidase A; Rats; Renin; Renin-Angiotensin System; Thermogenesis | 2003 |
Obesity-associated activation of angiotensin and endothelin in the cardiovascular system.
Topics: Adipocytes; Adiponectin; Angiotensin II; Animals; Endothelin-1; Endothelium, Vascular; Hormones, Ectopic; Humans; Hypertension; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Kidney; Leptin; Mice; Nerve Growth Factor; Obesity; Proteins; Rats; Renin-Angiotensin System; Resistin | 2003 |
Contribution of salt intake to insulin resistance associated with hypertension.
Topics: Angiotensin II; Animals; Diet, Sodium-Restricted; Disease Models, Animal; Humans; Hypertension; Insulin; Insulin Resistance; Oxidative Stress; Potassium, Dietary; Rats; Rats, Inbred Dahl; Signal Transduction; Sodium Chloride, Dietary | 2003 |
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Diabetes Complications; Diabetes Mellitus; Humans; Insulin Resistance; Kidney Failure, Chronic; Rats | 2003 |
Pathophysiologic implications of angiotensin I-converting enzyme as a mechanosensor: diabetes.
Topics: Aging; Angiotensin II; Animals; Blood Vessels; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Heart Diseases; Humans; Insulin Resistance; Mechanoreceptors; Peptidyl-Dipeptidase A | 2003 |
[Hemodynamic factors].
Topics: Angiotensin II; Animals; Diabetes Mellitus; Disease Models, Animal; Humans; Hypertension; Insulin; Insulin Resistance; Oxidative Stress; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Signal Transduction | 2003 |
[Oxidative stress].
Topics: Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Insulin Resistance; Lipid Metabolism; Nitric Oxide; Oxidants; Oxidative Stress; Reactive Oxygen Species | 2003 |
Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
Topics: Angiotensin II; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin; Insulin Resistance; Obesity; Risk Factors | 2004 |
Insulin resistance and hypertension.
Topics: Angiotensin II; Animals; Endothelium, Vascular; Glucose; Humans; Hypertension; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress | 2004 |
Angiotensin in atherosclerosis.
Topics: Angiotensin II; Arteriosclerosis; Diabetes Mellitus; Disease Progression; Estrogens; Humans; Hyperlipidemias; Hypertension; Inflammation; Insulin Resistance; Risk Factors | 2004 |
[Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].
Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Cardiomegaly; Clinical Trials as Topic; Coronary Restenosis; Humans; Hypertension; Hypertension, Renal; Insulin Resistance; Losartan; Ramipril; Receptor, Angiotensin, Type 1 | 2004 |
The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss.
Topics: Acute-Phase Proteins; Adipose Tissue; Angiotensin II; Angiotensinogen; C-Reactive Protein; Humans; Inflammation; Insulin Resistance; Interleukin-6; Liver; Lymphotoxin-alpha; Morbidity; Obesity; Tumor Necrosis Factor-alpha; Weight Loss | 2004 |
Angiotensin II-induced insulin resistance and protein tyrosine phosphatases.
Topics: Angiotensin II; Animals; Humans; Insulin Resistance; Protein-Tyrosine Kinases; Signal Transduction | 2004 |
[Protective effects of antioxidants against cardiovascular damage].
Topics: Adrenomedullin; Angiotensin II; Animals; Antioxidants; Cardiovascular Diseases; Cyclic N-Oxides; Humans; Insulin Resistance; Life Style; Lipoproteins, LDL; Nitric Oxide; Oxidative Stress; Peptides; Reactive Oxygen Species; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Spin Labels | 2004 |
Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Humans; Inflammation; Insulin Resistance; Metabolic Syndrome; Obesity; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System | 2005 |
Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Chromatography; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Glucose; Hyperglycemia; Immunoblotting; Insulin; Insulin Resistance; Kidney; Male; Models, Statistical; Obesity; Proteinuria; Radioimmunoassay; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation | 2006 |
Signaling crosstalk angiotensin II receptor subtypes and insulin.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucose; Humans; Hypertension; Insulin; Insulin Resistance; Mice; Models, Animal; Rats; Receptor Cross-Talk; Receptors, Angiotensin; Risk Factors; Signal Transduction | 2006 |
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Heart Failure; Humans; Hypertension; Insulin Resistance; Metabolic Syndrome; Renin-Angiotensin System; Sympathetic Nervous System | 2006 |
[Development of animal models for the metabolic syndrome with hypertension].
Topics: Angiotensin II; Animals; Disease Models, Animal; Hypertension; Insulin Resistance; Metabolic Syndrome; Mice; Mutation; Obesity; Rats; Rats, Inbred SHR; Receptors, Cell Surface; Receptors, Leptin; Tumor Necrosis Factor-alpha | 2006 |
Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome.
Topics: Adrenomedullin; Angiotensin II; Cardiovascular Diseases; Humans; Hypertension; Insulin Resistance; Metabolic Syndrome; Renin-Angiotensin System; Sodium Chloride | 2006 |
Mechanisms of protective effects induced by blockade of the renin-angiotensin system: novel role of the pancreatic islet angiotensin-generating system in Type 2 diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Heart Failure; Humans; Hypertension; Insulin Resistance; Islets of Langerhans; Renin-Angiotensin System; Vasoconstrictor Agents | 2007 |
Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Animals; Cardiovascular Diseases; Complement Activation; Complement C3a; Complement Factor D; Cytokines; Diabetes Mellitus, Type 2; Fibrinolysis; Humans; Inflammation; Insulin Resistance; Interleukin-6; Leptin; Nicotinamide Phosphoribosyltransferase; Obesity; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Resistin; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Risk Factors; Tumor Necrosis Factor-alpha | 2007 |
[Insulin and angiotensin II signaling pathways cross-talk: implications with the association between diabetes mellitus, arterial hypertension and cardiovascular disease].
Topics: Angiotensin II; Animals; Diabetes Mellitus; Humans; Hypertension; Insulin; Insulin Resistance; MAP Kinase Signaling System; Signal Transduction; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins | 2007 |
Improvement of insulin sensitivity by antagonism of the renin-angiotensin system.
Topics: Adipose Tissue; Angiotensin II; Child; Diabetes Mellitus, Type 2; Glucose; Humans; Insulin Resistance; Metabolic Syndrome; Muscle, Skeletal; Renin-Angiotensin System | 2007 |
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
Topics: Angiotensin II; Animals; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Hypertension; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Kidney Diseases; Metabolic Syndrome; Mineralocorticoids; Muscle, Skeletal; Myocardium; Oxidative Stress; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Signal Transduction | 2007 |
Diabetes mellitus and macrovascular disease: mechanisms and mediators.
Topics: Adiponectin; Angiotensin II; Animals; Atherosclerosis; Blood Coagulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Insulin Resistance; Peroxisome Proliferator-Activated Receptors | 2007 |
The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Diabetes Mellitus; Homeostasis; Humans; Hypertension; Insulin; Insulin Resistance; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2008 |
[Multiphasic action of AT1 receptor blockers and their therapeutic effects for cardiovascular diseases].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Endothelium, Vascular; Humans; Insulin Resistance; MAP Kinase Kinase Kinase 5; Metabolic Syndrome; Oxidative Stress | 2008 |
[Clinical pharmacology of renin-angiotensin system].
Topics: Angiotensin II; Animals; Diet, Sodium-Restricted; Disease Models, Animal; Endothelium, Vascular; Fatty Acids, Nonesterified; Humans; Insulin Resistance; Renin-Angiotensin System | 2008 |
Clinical review 79: Angiotensin II: an insulin-sensitizing vasoactive hormone?
Topics: Angiotensin II; Animals; Blood Vessels; Diabetes Mellitus, Type 2; Heart; Hemodynamics; Humans; Insulin; Insulin Resistance; Kidney; Regional Blood Flow; Renin-Angiotensin System; Vasoconstrictor Agents | 1996 |
The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity.
Topics: Adipose Tissue; Angiotensin II; Animals; Dietary Fats; Humans; Hypertrophy; Insulin Resistance; Mice; Obesity; Rats; Receptors, Angiotensin; Renin-Angiotensin System | 1995 |
Endothelin: role in experimental hypertension.
Topics: Angiotensin II; Animals; Desoxycorticosterone; Disease Models, Animal; Endothelin-1; Fructose; Hypertension; Insulin Resistance; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred Dahl; Rats, Inbred SHR | 2000 |
Fat cell metabolism: insulin, fatty acids, and renin.
Topics: Adipocytes; Angiotensin II; Animals; Fatty Acids; Humans; Hypertension; Insulin; Insulin Resistance; Obesity; Renin; Risk Factors | 2000 |
Effects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Hemodynamics; Humans; Insulin; Insulin Resistance; Models, Animal; Muscle, Smooth, Vascular; Natriuresis; Receptors, Angiotensin; Renin-Angiotensin System; Sympathetic Nervous System | 2000 |
11 trial(s) available for angiotensin ii and Insulin Resistance
| Article | Year |
|---|---|
RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.
Topics: Adiposity; Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Female; HIV Infections; HIV-1; Humans; Inflammation; Insulin Resistance; Intra-Abdominal Fat; Male; Middle Aged; Obesity, Abdominal; Renin-Angiotensin System; Young Adult | 2015 |
Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome.
Topics: Adult; Angiotensin II; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular System; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Hemodynamics; Humans; Insulin Resistance; Male; Metabolic Syndrome; Nitric Oxide Synthase; omega-N-Methylarginine; Photoplethysmography; Receptor, Angiotensin, Type 1; Telmisartan; Vascular Resistance | 2009 |
Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Endothelium, Vascular; Female; Fibrinolysis; Humans; Hypertension; Imidazolidines; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Signal Transduction; Single-Blind Method; Tetrazoles; Tissue Plasminogen Activator; Treatment Outcome; Young Adult | 2011 |
Decreased insulin sensitivity during dietary sodium restriction is not mediated by effects of angiotensin II on insulin action.
Topics: Adipocytes; Adult; Angiotensin II; Cells, Cultured; Cross-Over Studies; Diet, Sodium-Restricted; Double-Blind Method; Fatty Acids, Nonesterified; Female; Glucose; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Lipolysis; Male; Renin-Angiotensin System; Sodium, Dietary | 2003 |
Effect of short-term ACE inhibitor treatment on peripheral insulin sensitivity in obese insulin-resistant subjects.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Double-Blind Method; Fatty Acids, Nonesterified; Glucose Clamp Technique; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Middle Aged; Placebos; Ramipril | 2006 |
Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Diet; Fructose; Glucose Clamp Technique; Humans; Hypertension; Indans; Insulin Resistance; Male; Middle Aged; Rats; Rats, Sprague-Dawley; Tetrazoles | 1995 |
The effect of dietary salt on insulin sensitivity.
Topics: Adult; Angiotensin II; Blood Glucose; Diet, Sodium-Restricted; Glucose Clamp Technique; Hemodynamics; Humans; Hypertension; Insulin; Insulin Resistance; Male; Potassium; Renin; Sodium Chloride, Dietary | 1995 |
Stimulatory effect of insulin on tubular sodium reabsorption in normotensive subjects with a positive family history of hypertension.
Topics: Adult; Angiotensin II; Blood Glucose; Female; Glucose Clamp Technique; Hemodynamics; Humans; Hyperinsulinism; Hypertension; Insulin; Insulin Resistance; Kidney Tubules; Male; Middle Aged; Pedigree; Potassium; Sodium; Vasoconstrictor Agents | 1996 |
Treatment of non-insulin-dependent diabetic hypertensive patients with Ca2+ channel blockers is associated with increased platelet sensitivity to insulin.
Topics: Angiotensin II; Antihypertensive Agents; Blood Platelets; Blood Pressure; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diltiazem; Double-Blind Method; Female; Humans; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Isradipine; Male; Middle Aged; Vasoconstrictor Agents | 1995 |
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Hemodynamics; Humans; Hypertension; Indoles; Insulin Resistance; Losartan; Male; Middle Aged; Obesity; Perindopril | 1998 |
Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Double-Blind Method; Female; Fibrinolysis; Humans; Hypertension; Indoles; Insulin; Insulin Resistance; Lipids; Losartan; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Sensitivity and Specificity; Women's Health | 2001 |
141 other study(ies) available for angiotensin ii and Insulin Resistance
| Article | Year |
|---|---|
T Cell-based RAS Activity and Insulin Levels in Obese Subjects with Low Grade Inflammation.
Topics: Angiotensin II; C-Reactive Protein; Cytokines; Humans; Inflammation; Insulin; Insulin Resistance; Obesity; Peptidyl-Dipeptidase A; Renin-Angiotensin System; T-Lymphocytes | 2022 |
A knock-in mutation at cysteine 144 of TRIM72 is cardioprotective and reduces myocardial TRIM72 release.
Topics: Angiotensin II; Animals; Cardiomegaly; Coronary Artery Disease; Cysteine; Disease Models, Animal; Gene Knock-In Techniques; Insulin Resistance; Membrane Proteins; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Myocardial Reperfusion Injury; Myocardium | 2019 |
Silencing of CRT relieves Ang II-Induced injury of HUVECs with insulin resistance.
Topics: Angiotensin II; Apoptosis; bcl-2-Associated X Protein; Calreticulin; Cell Survival; Enzyme-Linked Immunosorbent Assay; Gene Silencing; Glucose; Glycogen; Human Umbilical Vein Endothelial Cells; Humans; Insulin; Insulin Resistance; Proto-Oncogene Proteins c-bcl-2 | 2021 |
Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus.
Topics: Aged; Albuminuria; Angiotensin II; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Early Diagnosis; Endothelium, Vascular; Female; Hospitals, University; Humans; Insulin Resistance; Male; Microvessels; Middle Aged; Outpatient Clinics, Hospital; Prediabetic State; Republic of Korea; Risk Factors; Up-Regulation; Vasculitis | 2017 |
Esculetin ameliorates vascular perturbation by intervening in the occupancy of H2BK120Ub at At1, At2, Tgfβ1 and Mcp1 promoter gene in thoracic aorta of IR and T2D rats.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blood Vessels; Chemokine CCL2; Diabetes Mellitus, Type 2; Gene Expression Regulation; Hemodynamics; Histones; Insulin Resistance; Lysine; Muscle Relaxation; Myocardial Contraction; Promoter Regions, Genetic; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Transforming Growth Factor beta1; Ubiquitin; Umbelliferones | 2017 |
Egg White Ovotransferrin-Derived ACE Inhibitory Peptide Ameliorates Angiotensin II-Stimulated Insulin Resistance in Skeletal Muscle Cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cells, Cultured; Conalbumin; Glucose; Insulin Resistance; Muscle Fibers, Skeletal; Muscle, Skeletal; NADPH Oxidases; Peptides; Rats; Reactive Oxygen Species | 2018 |
Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue.
Topics: Adaptor Proteins, Signal Transducing; Adipose Tissue; Angiotensin II; Animals; Glucose; Glucose Transporter Type 4; Infusions, Intravenous; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Transgenic; Muscle, Skeletal; Oxidative Stress; p38 Mitogen-Activated Protein Kinases | 2018 |
Valsartan Alleviates Insulin Resistance in Skeletal Muscle of Chronic Renal Failure Rats.
Topics: Angiotensin II; Animals; Cell Line; Glucose; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Kidney Failure, Chronic; Male; Muscle, Skeletal; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Valsartan | 2018 |
Acute, local infusion of angiotensin II impairs microvascular and metabolic insulin sensitivity in skeletal muscle.
Topics: Angiotensin II; Animals; Blood Glucose; Energy Metabolism; Hemodynamics; Hypoglycemic Agents; Infusions, Intra-Arterial; Infusions, Intravenous; Insulin; Insulin Resistance; Liver; Male; Microcirculation; Muscle, Skeletal; Rats, Sprague-Dawley; Time Factors; Vasoconstrictor Agents | 2019 |
Pancreatic AT1aR Deficiency Decreases Insulin Secretion in Obese C57BL/6 Mice.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Biomarkers; Blood Glucose; Diet, Fat-Restricted; Diet, High-Fat; Disease Models, Animal; Insulin; Insulin Resistance; Islets of Langerhans; Male; Mice, Inbred C57BL; Mice, Knockout; Obesity; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Secretory Pathway | 2019 |
Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose tissue.
Topics: Adipose Tissue, White; Adiposity; Angiotensin I; Angiotensin II; Animals; Biomarkers; Body Weight; Feeding Behavior; Glucose; Insulin Resistance; Male; Mice, Inbred C57BL; Obesity; Peptide Fragments; Peptides; Physical Conditioning, Animal; Renin-Angiotensin System; RNA, Messenger; Subcutaneous Fat; Thermogenesis; Uncoupling Protein 1 | 2019 |
Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs).
Topics: Adult; Angiotensin II; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Peptidyl-Dipeptidase A; Polycystic Ovary Syndrome; Renin; Renin-Angiotensin System; Up-Regulation; Young Adult | 2013 |
Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.
Topics: Adaptor Proteins, Signal Transducing; Adenoviridae; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Genetic Therapy; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Vasoconstrictor Agents | 2013 |
Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.
Topics: Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Mesenteric Arteries; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Signal Transduction; Vasodilation | 2013 |
Serine phosphorylation sites on IRS2 activated by angiotensin II and protein kinase C to induce selective insulin resistance in endothelial cells.
Topics: Angiotensin II; Animals; Cattle; Cell Line; Endothelial Cells; Enzyme Activation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Mice; Mice, Transgenic; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Zucker; Serine; Tetradecanoylphorbol Acetate; Threonine; Tyrosine | 2013 |
Beneficial effects of β-conglycinin on renal function and nephrin expression in early streptozotocin-induced diabetic nephropathy rats.
Topics: Angiotensin II; Animals; Antigens, Plant; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Proteins; Globulins; Glycation End Products, Advanced; Glycine max; Insulin Resistance; Isoflavones; Kidney; Male; Membrane Proteins; Peptidyl-Dipeptidase A; Phytotherapy; Plant Preparations; Rats; Rats, Inbred SHR; Seed Storage Proteins; Soybean Proteins; Thiobarbituric Acid Reactive Substances; Triglycerides | 2014 |
Central insulin-angiotensin II interaction in blood pressure regulation in fructose overloaded rats.
Topics: Angiotensin II; Animals; Blood Pressure; Fructose; Hypothalamus; Injections, Intraventricular; Insulin; Insulin Resistance; Male; MAP Kinase Signaling System; Metabolic Syndrome; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasoconstrictor Agents; Vasomotor System | 2013 |
Enhanced development of azoxymethane-induced colonic preneoplastic lesions in hypertensive rats.
Topics: Adipose Tissue; Angiotensin II; Animals; Azoxymethane; Carcinogens; Catalase; Chemokine CCL2; Colorectal Neoplasms; Cyclooxygenase 2; Glutathione Peroxidase; Hypertension; Insulin Resistance; Interleukin-6; Intestinal Mucosa; Male; Nitric Oxide Synthase Type II; Oxidative Stress; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Zucker; RNA, Messenger; Tumor Necrosis Factor-alpha | 2013 |
High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells.
Topics: Angiotensin II; Animals; Cell Line; Cystinyl Aminopeptidase; Glucose; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction | 2013 |
Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Glucose; Insulin Resistance; Male; Muscle, Skeletal; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin-Angiotensin System | 2014 |
Selective alpha(1)-adrenoceptor blockade prevents fructose-induced hypertension.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Pressure; Fructose; Hypertension; Insulin Resistance; Male; Norepinephrine; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Uric Acid | 2014 |
Superoxide anions in the paraventricular nucleus mediate cardiac sympathetic afferent reflex in insulin resistance rats.
Topics: Afferent Pathways; Angiotensin II; Animals; Baroreflex; Blood Pressure; Heart Rate; Insulin Resistance; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Superoxides; Sympathetic Nervous System | 2014 |
Abrogation of adenosine A1 receptor signalling improves metabolic regulation in mice by modulating oxidative stress and inflammatory responses.
Topics: Adipose Tissue; Aging; Angiotensin II; Animals; Body Composition; CD4-Positive T-Lymphocytes; Cytokines; Female; Glucose Intolerance; Inflammation; Insulin; Insulin Resistance; Islets of Langerhans; Male; Membrane Glycoproteins; Metabolism; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Receptor, Adenosine A1; Regional Blood Flow; Signal Transduction | 2015 |
Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.
Topics: Administration, Oral; Allopurinol; Angiotensin II; Animals; Diet, High-Fat; Electrocardiography; Enzyme Inhibitors; Hemodynamics; Inflammation; Insulin Resistance; Isoproterenol; Male; Myocardial Ischemia; Myocardium; Oxidative Stress; Rats, Wistar; Ultrasonography; Uric Acid; Xanthine Oxidase | 2015 |
Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Benzimidazoles; Benzoates; Diet; Energy Intake; Energy Metabolism; Insulin Resistance; Leptin; Male; Obesity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Signal Transduction; Telmisartan; Weight Gain; Weight Loss | 2015 |
Skeletal muscle insulin resistance in salt-sensitive hypertension: role of angiotensin II activation of NFκB.
Topics: Angiotensin II; Animals; Hypertension; Insulin Resistance; Male; Muscle, Skeletal; NF-kappa B; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Sodium Chloride, Dietary | 2015 |
Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin II.
Topics: Acetylcarnitine; Angiotensin II; Animals; Cell Line; Insulin Resistance; Mitochondria; Muscle, Skeletal; Rats; Reactive Oxygen Species; Sirtuin 3 | 2015 |
Protective role of oleic acid against cardiovascular insulin resistance and in the early and late cellular atherosclerotic process.
Topics: Angiotensin II; Animals; Apoptosis; Atherosclerosis; Blotting, Western; Cell Line; Cell Proliferation; Chemokine CCL2; Inflammation; Insulin Resistance; Intercellular Adhesion Molecule-1; MAP Kinase Signaling System; Mice; Muscle, Smooth, Vascular; Myocytes, Cardiac; Myocytes, Smooth Muscle; NF-kappa B; Nitric Oxide Synthase Type III; Oleic Acid; Palmitates; Palmitic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2015 |
Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis.
Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; Cardiotonic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrosis; Heart Diseases; Insulin Resistance; Male; Rats; Rats, Wistar; Telmisartan; Treatment Outcome; Umbelliferones; Vasoconstriction | 2015 |
Long-Term Supplementation of Microencapsulated ursodeoxycholic Acid Prevents Hypertension in a Mouse Model of Insulin Resistance.
Topics: Angiotensin II; Animals; Capsules; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Hypertension; Insulin Resistance; Male; Mice; Time Factors; Ursodeoxycholic Acid | 2017 |
Healthy ageing of cloned sheep.
Topics: Adiposity; Aging; Angiotensin II; Animals; Blood Pressure; Body Composition; Cloning, Organism; Embryo Transfer; Glucose Tolerance Test; Heart Rate; Insulin Resistance; Joints; Magnetic Resonance Imaging; Sheep; Systole | 2016 |
Metformin Improves Metabolic Memory in High Fat Diet (HFD)-induced Renal Dysfunction.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Apoptosis; Blood Glucose; Cardiovascular System; Caspase 3; Cyclooxygenase 2; Diet, High-Fat; Hypoglycemic Agents; Insulin Resistance; Interleukin-1beta; Kidney; Male; Metformin; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley | 2016 |
Effects of various types of anesthesia on hemodynamics, cardiac function, and glucose and lipid metabolism in rats.
Topics: Aldosterone; Anesthetics, Dissociative; Anesthetics, Inhalation; Angiotensin II; Animals; Aorta; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dopamine; Echocardiography; Epinephrine; Fatty Acids, Nonesterified; Glucose; Heart Rate; Hemodynamics; Hypnotics and Sedatives; Insulin; Insulin Resistance; Isoflurane; Ketamine; Lipid Metabolism; Male; Norepinephrine; Pentobarbital; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Triglycerides; Xylazine | 2016 |
Low-protein diet supplemented with ketoacids ameliorates proteinuria in 3/4 nephrectomised rats by directly inhibiting the intrarenal renin-angiotensin system.
Topics: Angiotensin II; Animals; Cell Line; Diet, Protein-Restricted; Dietary Supplements; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Insulin Resistance; Keto Acids; Kidney; Male; Mesangial Cells; Nephrectomy; Oxidative Stress; Proteinuria; Proteomics; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Uremia | 2016 |
Chronic blockade of the AT2 receptor with PD123319 impairs insulin signaling in C57BL/6 mice.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Chemokine CCL2; Diabetes Mellitus, Type 2; Humans; Hypertension; Imidazoles; Insulin; Insulin Resistance; Interleukin-6; Losartan; Mice; Mice, Knockout; Pyridines; Receptor, Angiotensin, Type 2; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |
Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II.
Topics: Angiotensin II; Animals; Antioxidants; Catalase; Disease Models, Animal; Fenofibrate; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Myocardial Infarction; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoinositide-3 Kinase Inhibitors; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Superoxide Dismutase; Superoxide Dismutase-1; Triglycerides | 2016 |
Angiotensin II induces differential insulin action in rat skeletal muscle.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Eating; Glucose Transporter Type 4; Insulin; Insulin Resistance; Male; Muscle, Skeletal; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction | 2017 |
Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation.
Topics: Adenoviridae; Angiotensin II; Animals; Aorta; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Models, Animal; Genetic Vectors; Humans; Insulin; Insulin Resistance; Male; Microtubule-Associated Proteins; Muscle, Smooth, Vascular; Myography; Nitric Oxide Synthase Type II; Phosphorylation; Protein Phosphatase 1; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred WKY; Recombinant Proteins; RNA Interference; Signal Transduction; Survivin; Transfection; Vasoconstriction; Vasodilation | 2009 |
Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats.
Topics: Angiotensin II; Animals; Blood Pressure; Dietary Carbohydrates; Endothelin-1; Fructose; Glucose Tolerance Test; Hypertension; Imidazoles; Immunohistochemistry; Insulin Resistance; Male; Rats; Rats, Wistar; Tetrazoles | 2009 |
Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; C-Reactive Protein; Cyclic N-Oxides; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Signal Transduction; Sodium Chloride, Dietary; Spin Labels; Superoxide Dismutase; Tetrazoles; Vasodilation; Vasodilator Agents | 2009 |
Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression.
Topics: Amides; Angiotensin II; Animals; Animals, Genetically Modified; Disease Models, Animal; Fumarates; Gene Expression Regulation; Glucose; Glucose Transporter Type 4; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Muscle, Skeletal; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reactive Nitrogen Species; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Renin | 2009 |
[The effect and pathophysiological mechanism of high free fatty acids(FfAs) on the cardiac structure and function].
Topics: Angiotensin II; Animals; Fatty Acids, Nonesterified; I-kappa B Proteins; Insulin Resistance; Male; Myocardial Contraction; Myocardium; NF-kappa B; Nitric Oxide Synthase Type II; Obesity; Random Allocation; Rats; Rats, Sprague-Dawley; Triglycerides | 2009 |
Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Insulin Resistance; Leptin; Lipoprotein Lipase; Male; Middle Aged; Obesity; Tomography, X-Ray Computed; Weight Loss | 2009 |
Possible contribution of the non-proteolytic activation of prorenin to the development of insulin resistance in fructose-fed rats.
Topics: Adipocytes; Adiponectin; Angiotensin II; Animals; Base Sequence; Blood Glucose; Blood Pressure; Cell Size; Cholesterol; Dietary Carbohydrates; Enzyme Activation; Fatty Acids, Nonesterified; Fructose; Insulin; Insulin Resistance; Male; Muscle, Skeletal; Oligopeptides; Prorenin Receptor; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Renin; RNA, Messenger; Triglycerides | 2009 |
Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation.
Topics: Adipose Tissue; Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Cell Movement; Cytokines; Dietary Fats; Inflammation; Insulin Resistance; Macrophages; Male; Mice; Mice, Inbred C57BL; Obesity; Systole | 2009 |
Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats.
Topics: Acetylcholine; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Cyclooxygenase 2; Dietary Fats; Endothelium, Vascular; Hypertension; I-kappa B Kinase; Insulin Resistance; Kidney; Lipids; Male; Nephritis; NF-kappa B; Nitrites; Obesity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents; Weight Gain | 2010 |
Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.
Topics: Angiotensin II; Animals; Cell Line; Enzyme Inhibitors; ErbB Receptors; Hepatocytes; Insulin; Insulin Resistance; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Receptor, Insulin; Serine; Signal Transduction; Threonine; Transcriptional Activation; Tyrphostins; Vasoconstrictor Agents | 2010 |
Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Dietary Carbohydrates; Disease Models, Animal; Fructose; Hypertension; Hypertrophy, Left Ventricular; Insulin; Insulin Resistance; Male; Peptide Fragments; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2010 |
Aldosterone production and insulin resistance in healthy adults.
Topics: Adolescent; Adult; Aged; Aging; Aldosterone; Angiotensin II; Blood Pressure; Body Mass Index; Female; Humans; Insulin Resistance; Male; Middle Aged; Predictive Value of Tests; Reference Values; Sex Characteristics; Stimulation, Chemical; Young Adult | 2010 |
Hypertension, obesity, and inflammation: the complex designs of a deadly trio.
Topics: Adaptive Immunity; Angiotensin II; Atherosclerosis; Genes, ras; Humans; Hypertension; Inflammation; Insulin Resistance; Metabolic Syndrome; Obesity; Oxidative Stress | 2010 |
[Contribution of apelin to water balance, blood glucose control, and cardiovascular functions].
Topics: Adipose Tissue; Amino Acid Sequence; Angiotensin II; Animals; Apelin; Blood Glucose; Blood Pressure; Cattle; Diuresis; Diuretics; Heart; Humans; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Kidney; Male; Mice; Molecular Sequence Data; Muscle, Skeletal; Rats; Vasopressins; Water-Electrolyte Balance | 2010 |
Angiotensin II enhances insulin-stimulated whole-body glucose disposal but impairs insulin-induced capillary recruitment in healthy volunteers.
Topics: Adult; Angiotensin II; Blood Pressure; Capillaries; Female; Glucose; Glucose Clamp Technique; Heart Rate; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male; Microscopic Angioscopy; Middle Aged | 2010 |
Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Body Composition; Diet; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Insulin Resistance; Kidney; Male; Obesity; Rats; Rats, Zucker; Receptors, Dopamine; Sex Characteristics; Sodium Chloride, Dietary; Tetrazoles | 2010 |
Low-salt diet increases insulin resistance in healthy subjects.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Body Mass Index; Diet, Sodium-Restricted; Epinephrine; Female; Homeostasis; Humans; Insulin Resistance; Male; Middle Aged; Norepinephrine; Potassium; Renin; Sodium; Sodium Chloride, Dietary; Young Adult | 2011 |
Angiotensin blockade in diabetic patients decreases insulin resistance-associated low-grade inflammation.
Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Female; Humans; Inflammation Mediators; Insulin Resistance; Interleukin-6; Male; Middle Aged; Regression Analysis; Tetrazoles; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2011 |
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia.
Topics: Adamantane; Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Hypertension; Insulin Resistance; Mice; Obesity; Rats; Urea | 2011 |
Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation.
Topics: Adipose Tissue; Angiotensin II; Humans; Hyperoxia; Inflammation; Insulin Resistance; Isoproterenol; Male; Microcirculation; Middle Aged; Mitochondria; Obesity; Oxygen; Oxygen Consumption; Regional Blood Flow; Thinness; Vasoconstrictor Agents; Vasodilator Agents | 2011 |
Angiotensin II shifts insulin signaling into vascular remodeling from glucose metabolism in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Cell Size; Cells, Cultured; Glucose; Hypertrophy; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Protein Biosynthesis; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2011 |
Vascular smooth muscle insulin resistance, but not hypertrophic signaling, is independent of angiotensin II-induced IRS-1 phosphorylation by JNK.
Topics: Actins; Angiotensin II; Animals; Blotting, Western; Enzyme Inhibitors; Hypertrophy; Immunoprecipitation; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Rats; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transfection | 2011 |
Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blotting, Western; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Focal Adhesion Kinase 2; Immunohistochemistry; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Losartan; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; src-Family Kinases; Vasodilation; Vasodilator Agents | 2011 |
Candesartan restored cardiac Hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cells, Cultured; Dietary Fats; Disease Models, Animal; Genetic Predisposition to Disease; Glucose Tolerance Test; Glucose Transporter Type 4; Heredity; HSP72 Heat-Shock Proteins; Hyperthermia, Induced; Insulin Resistance; Male; Myocardial Reperfusion Injury; Myocardium; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Recovery of Function; Tetrazoles; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Angiotensin II receptor activation in youth triggers persistent insulin resistance and hypertension--a legacy effect?
Topics: Aging; Angiotensin II; Animals; Blood Pressure; Body Weight; Chemokine CCL2; Disease Models, Animal; Hypertension; Insulin Resistance; Muscle, Skeletal; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Angiotensin; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2012 |
'Memory' and 'legacy' in hypertension and lifestyle-related diseases.
Topics: Aging; Angiotensin II; Animals; Hypertension; Insulin Resistance; Receptors, Angiotensin | 2012 |
Co-effect of insulin resistance and biomarkers of inflammation and endothelial dysfunction on hypertension.
Topics: Adult; Angiotensin II; Asian People; Biomarkers; Blood Glucose; C-Reactive Protein; E-Selectin; Endothelium, Vascular; Female; Humans; Hypertension; Inflammation; Insulin; Insulin Resistance; Intercellular Adhesion Molecule-1; Male; Middle Aged; Prevalence; Risk | 2012 |
The effect of losartan and carvedilol on renal haemodynamics and altered metabolism in fructose-fed Sprague-Dawley rats.
Topics: Angiotensin II; Animals; Body Weight; Carbazoles; Carvedilol; Fructose; Glucose Tolerance Test; Hemodynamics; Insulin Resistance; Kidney; Losartan; Male; Norepinephrine; Phenylephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2012 |
The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7).
Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Dyslipidemias; Fructose; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; GTPase-Activating Proteins; Hypertension; Insulin; Insulin Resistance; Liver; Male; Muscle, Skeletal; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction | 2012 |
Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diet, High-Fat; Dietary Carbohydrates; Energy Intake; Glucose; Glucose Intolerance; Glucose Transporter Type 4; Homeostasis; Insulin Resistance; MEF2 Transcription Factors; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Myoblasts; Myogenic Regulatory Factors; Peptide Fragments; Peptidyl-Dipeptidase A | 2013 |
ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle.
Topics: Angiotensin II; Animals; Biological Transport; Female; Glucose; In Vitro Techniques; Insulin Resistance; Muscle, Skeletal; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Zucker; Receptors, G-Protein-Coupled | 2012 |
[Effects of liver hydrolysate on the blood glucose in metabolic syndrome model rats (SHR/NDmcr-cp)].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blood Glucose; Depression, Chemical; Disease Models, Animal; Glucose Tolerance Test; Glycated Hemoglobin; Insulin Resistance; Liver; Male; Metabolic Syndrome; Oxidative Stress; Protein Hydrolysates; Rats; Rats, Inbred SHR | 2013 |
ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Echocardiography; Energy Metabolism; Fatty Acids; Glucose; Glucose Tolerance Test; Heart; Heart Failure, Diastolic; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Oxidation-Reduction; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvate Dehydrogenase Complex; Renin-Angiotensin System; Sirtuin 3 | 2013 |
Role of ANG II in coronary capillary angiogenesis at the insulin-resistant stage of a NIDDM rat model.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Capillaries; Coronary Circulation; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Growth Factors; Extracellular Matrix Proteins; Gene Expression; Glycation End Products, Advanced; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin Resistance; Lymphokines; Male; Neovascularization, Physiologic; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Receptor Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Tetrazoles; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Angiotensin blockade prevents type 2 diabetes by formation of fat cells.
Topics: Adipocytes; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cell Differentiation; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Telmisartan | 2002 |
Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling.
Topics: Adipocytes; Angiotensin II; Animals; Antioxidants; Cells, Cultured; Cyclic N-Oxides; Glucose; Glucose Clamp Technique; Glucose Transporter Type 4; Glycogen Synthase; Hepatocytes; Hyperinsulinism; In Vitro Techniques; Infusions, Intravenous; Insulin; Insulin Resistance; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Spin Labels | 2002 |
Leukocyte angiotensin II levels inpatients with essential hypertension:relation to insulin resistance.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Body Mass Index; Chromatography, High Pressure Liquid; Cilazapril; Female; Homeostasis; Humans; Hypertension; Insulin; Insulin Resistance; Leptin; Leukocytes; Male; Middle Aged | 2003 |
Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats.
Topics: Angiotensin II; Animals; Collagen Type I; Collagen Type III; Coronary Vessels; Diabetes Mellitus, Type 2; Down-Regulation; Fibrin; Fibrosis; Insulin Resistance; Matrix Metalloproteinase 2; Matrix Metalloproteinases; Rats; Rats, Inbred OLETF; Receptor, Melatonin, MT1; Transforming Growth Factor beta | 2003 |
The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; GRB2 Adaptor Protein; Hypoglycemic Agents; Insulin; Insulin Resistance; Janus Kinase 2; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardium; Obesity; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Rats, Zucker; Receptor Cross-Talk; Vasoconstrictor Agents | 2003 |
Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Calcimycin; Culture Techniques; Endothelium, Vascular; Insulin Resistance; Losartan; Male; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylephrine; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; RNA, Messenger; Superoxides; Vasoconstriction; Vasoconstrictor Agents | 2004 |
Angiotensin II-induced insulin resistance is enhanced in adrenomedullin-deficient mice.
Topics: Adrenomedullin; Angiotensin II; Animals; Blood Pressure; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Peptides; Piperidines | 2004 |
G protein alpha(i2): a potential link between hypertension and insulin resistance?
Topics: Adult; Angiotensin II; Calcium; Cells, Cultured; Female; Fibroblasts; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; RNA, Messenger; Skin; Vasoconstrictor Agents | 2004 |
Abnormal regulation of G protein alpha(i2) subunit in skin fibroblasts from insulin-resistant hypertensive individuals.
Topics: Adult; Angiotensin II; Calcium; Cells, Cultured; Culture Media, Serum-Free; Fasting; Female; Fibroblasts; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; RNA, Messenger; Skin; Vasoconstrictor Agents | 2004 |
Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats.
Topics: Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Infusion Pumps, Implantable; Injections, Subcutaneous; Insulin Resistance; Liver; Male; Rats; Rats, Wistar; Triglycerides | 2004 |
Effects of angiotensin II and insulin on ERK1/2 activation in fibroblasts from hypertensive patients.
Topics: Adult; Angiotensin II; Biomarkers; Blood Pressure; Dose-Response Relationship, Drug; Enzyme Activation; Female; Fibroblasts; Humans; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Italy; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Phosphotransferases; Receptor, Angiotensin, Type 1; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2004 |
Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Collagen Type I; Coronary Disease; Coronary Vessels; Fibrosis; Heart Ventricles; Imidazoles; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinase 9; Mice; Mice, Obese; Obesity; Olmesartan Medoxomil; Phosphorylation; Plasminogen Activator Inhibitor 1; Tetrazoles; Thiazepines; Transforming Growth Factor beta | 2004 |
Vascular response to angiotensin II in upper body obesity.
Topics: Acetylcholine; Adult; Angiotensin II; Blood Glucose; Body Composition; Dose-Response Relationship, Drug; Forearm; Humans; Hypertension; Insulin Resistance; Lipolysis; Male; Nitric Oxide Synthase; Nitroprusside; Obesity; omega-N-Methylarginine; Palmitic Acid; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2004 |
Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression.
Topics: Administration, Oral; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclic N-Oxides; Disease Models, Animal; Glucose; Hypertension; Insulin; Insulin Resistance; Male; Muscle, Skeletal; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Spin Labels; Tetrazoles; Valine; Valsartan | 2005 |
Angiotensin II enhances insulin sensitivity in vitro and in vivo.
Topics: Adipocytes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Drug Synergism; Gene Expression; Glucose; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Insulin Resistance; Losartan; Male; Monosaccharide Transport Proteins; Muscle Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2005 |
Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance.
Topics: Adipocytes; Angiotensin II; Animals; Cell Size; Dietary Fats; Energy Metabolism; Hypertension; Imidazoles; Insulin Resistance; Mice; Mice, Knockout; Muscle, Skeletal; Obesity; Pyridines; Receptor, Angiotensin, Type 2 | 2005 |
ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Blood Vessels; Cell Membrane; Cytoplasm; Enzyme Activation; Enzyme Inhibitors; Glucose; Glucose Transporter Type 4; Hypertension; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monosaccharide Transport Proteins; Muscle Proteins; Myocytes, Smooth Muscle; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Serine; Tyrosine | 2005 |
PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
Topics: 3T3-L1 Cells; Adipocytes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Cycloheximide; Insulin Resistance; Irbesartan; Mice; Obesity; PPAR gamma; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Rats; Rats, Zucker; Receptor, Angiotensin, Type 2; Telmisartan; Tetrazoles | 2005 |
Selective angiotensin II receptor antagonism enhances whole-body insulin sensitivity and muscle glucose transport in hypertensive TG(mREN2)27 rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biological Transport; Biphenyl Compounds; Glucose; Glucose Transporter Type 4; Glycogen Synthase; Hypertension; Insulin Receptor Substrate Proteins; Insulin Resistance; Irbesartan; Male; Mice; Muscle, Skeletal; Phosphoproteins; Rats; Renin; Tetrazoles | 2005 |
Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Cyclic N-Oxides; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Free Radical Scavengers; Insulin Resistance; Male; Rats; Rats, Sprague-Dawley; Spin Labels; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2006 |
Insulin signaling, glucose metabolism, and the angiotensin II signaling system: studies in Bartter's/Gitelman's syndromes.
Topics: Angiotensin II; Bartter Syndrome; Case-Control Studies; Glucose; Humans; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Protein Serine-Threonine Kinases; rho-Associated Kinases; Signal Transduction | 2006 |
Galphai2 expression, hypertension and insulin resistance.
Topics: Angiotensin II; Animals; Fibroblasts; GTP-Binding Protein alpha Subunit, Gi2; Humans; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation | 2006 |
Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
Topics: Adiponectin; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Glucose; Dose-Response Relationship, Drug; Glucose Tolerance Test; Hypertension; Imidazoles; Injections, Subcutaneous; Insulin; Insulin Resistance; Leptin; Male; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptors, Adiponectin; Receptors, Cell Surface; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Chronic hyperinsulinemia enhances adrenergic vasoconstriction and decreases calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats.
Topics: Acetylcholine; Adrenergic Fibers; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Calcitonin Gene-Related Peptide; Cholesterol; Hyperinsulinism; Hypertension; Insulin; Insulin Resistance; Male; Nitroprusside; Norepinephrine; Rats; Rats, Wistar; Spinal Cord; Triglycerides; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2006 |
The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Vessels; Body Weight; Diet; Dose-Response Relationship, Drug; Eating; Glucose Tolerance Test; Heart Rate; Hypoglycemic Agents; Insulin Resistance; Membranes; Pioglitazone; PPAR gamma; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Renal Circulation; RNA, Messenger; Sodium; Sodium, Dietary; Thiazolidinediones | 2006 |
Nocturnal hypertension in mice consuming a high fructose diet.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Glucose; Body Weight; Brain Stem; Circadian Rhythm; Fructose; Glucose Intolerance; Glucose Tolerance Test; Heart Rate; Hypertension; Insulin; Insulin Resistance; Lipids; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Prazosin; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Sympathetic Nervous System; Tyrosine 3-Monooxygenase | 2006 |
Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats.
Topics: Adaptor Proteins, Signal Transducing; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Enzyme Activation; Fatty Liver; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Irbesartan; Male; Mitogen-Activated Protein Kinase 3; Obesity; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Zucker; Receptor, Insulin; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Tetrazoles | 2006 |
Blockade of the renin-angiotensin system improves insulin sensitivity in thermal injury.
Topics: Angiotensin II; Animals; Area Under Curve; Blood Glucose; Burns; Insulin; Insulin Resistance; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2006 |
Angiotensin II, corticosteroids, type II diabetes and the metabolic syndrome.
Topics: Adipocytes; Adrenal Cortex Hormones; Angiotensin II; Animals; Diabetes Mellitus, Type 2; Feedback, Physiological; Humans; Insulin Resistance; Metabolic Syndrome; Models, Biological; Renin-Angiotensin System | 2007 |
PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Male; Pioglitazone; PPAR gamma; Prediabetic State; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Rosiglitazone; Streptozocin; Thiazolidinediones; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production.
Topics: Angiotensin II; Animals; Aorta; Blotting, Western; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation; GTP Cyclohydrolase; Insulin Resistance; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Quinolines; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Superoxides | 2007 |
Genetic and dietary interactions: role of angiotensin AT1a receptors in response to a high-fructose diet.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Circadian Rhythm; Dietary Carbohydrates; Disease Models, Animal; Fructose; Glucose Intolerance; Heart Rate; Hypertension; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Prazosin; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha-1; Renin-Angiotensin System; Signal Transduction; Sympathetic Nervous System; Time Factors | 2007 |
Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells.
Topics: Aldosterone; Angiotensin II; Animals; Cells, Cultured; Down-Regulation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Muscle, Smooth, Vascular; Oncogene Protein v-akt; Phosphoproteins; Phosphorylation; Proteasome Endopeptidase Complex; Rats; Reactive Oxygen Species; Signal Transduction; src-Family Kinases | 2007 |
Arterial stiffness and haemodynamic response to vasoactive medication in subjects with insulin-resistance syndrome.
Topics: Adult; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Arteries; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Imidazoles; Insulin Resistance; Male; Middle Aged; Nitroglycerin; omega-N-Methylarginine; Photoplethysmography; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vascular Resistance; Vasoconstrictor Agents | 2008 |
The novel peptide apelin regulates intrarenal artery tone in diabetic mice.
Topics: Acetylcholine; Adipokines; Angiotensin II; Animals; Apelin; Apelin Receptors; Blotting, Western; Carrier Proteins; Diabetes Mellitus; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Nitric Oxide Synthase Type III; Receptors, G-Protein-Coupled; Renal Artery; Vasodilation | 2007 |
Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat.
Topics: Angiotensin II; Animals; Blood Pressure; Diet, Sodium-Restricted; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Insulin Resistance; Kidney Diseases; Mesenteric Artery, Superior; Norepinephrine; Obesity; Prediabetic State; Rats; Rats, Zucker; Renal Artery; Renal Circulation; Renin; Renin-Angiotensin System; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Clinical pathology and treatment of renin-angiotensin system 4. Renin-angiotensin system and insulin resistance.
Topics: Adiponectin; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelium, Vascular; Humans; Insulin Resistance; Oxidative Stress; Renin-Angiotensin System; Tumor Necrosis Factor-alpha | 2007 |
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
Topics: Adult; Aldosterone; Angiotensin II; Body Mass Index; Diet; Female; Humans; Hydrocortisone; Infusions, Intravenous; Insulin Resistance; Male; Middle Aged; Overweight; Renin; Sodium, Dietary; Vasoconstrictor Agents | 2007 |
WB1106, a novel nitric oxide-releasing derivative of telmisartan, inhibits hypertension and improves glucose metabolism in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Cyclic GMP; Diet; Dietary Carbohydrates; Dietary Fats; Glucose; Insulin Resistance; Male; Muscle Contraction; Muscle Relaxation; Nitric Oxide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Telmisartan; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Angiotensin II decreases glucose uptake by downregulation of GLUT1 in the cell membrane of the vascular smooth muscle cell line A10.
Topics: Actins; Angiotensin II; Animals; Cell Fractionation; Cell Line; Cell Membrane; Cytochalasin D; Down-Regulation; Glucose; Glucose Transporter Type 1; Insulin; Insulin Resistance; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Rats; Time Factors | 2007 |
Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Cells, Cultured; Cloning, Molecular; Humans; Insulin; Insulin Resistance; Macrophage Migration-Inhibitory Factors; Malondialdehyde; NADPH Oxidases; Peptidyl-Dipeptidase A; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction | 2008 |
Functional coupling of angiotensin II type 1 receptor with insulin resistance of energy substrate uptakes in immortalized cardiomyocytes (HL-1 cells).
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line; Cell Survival; Glucose; Hypertrophy; Insulin; Insulin Resistance; Mice; Myocytes, Cardiac; Palmitic Acid; Receptor, Angiotensin, Type 1 | 2008 |
Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase.
Topics: Aldehydes; Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Glucose Transporter Type 4; Insulin Resistance; Male; Muscle, Skeletal; NADPH Oxidases; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Transcription Factor RelA; Transfection; Tumor Necrosis Factor-alpha | 2008 |
Research profile. Places in the heart. Pinpointing the cause of cardiovascular complications.
Topics: Angiotensin II; Cardiovascular Diseases; Diabetic Angiopathies; Humans; Insulin Resistance | 2007 |
Pioglitazone opposes neurogenic vascular dysfunction associated with chronic hyperinsulinaemia.
Topics: Administration, Oral; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Chronic Disease; Disease Models, Animal; Hyperinsulinism; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Norepinephrine; Pioglitazone; Random Allocation; Rats; Rats, Wistar; Thiazolidinediones; Triglycerides; Vasoconstriction | 2008 |
Proapoptotic and antiapoptotic effects of hyperglycemia: role of insulin signaling.
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; bcl-2-Associated X Protein; Cells, Cultured; Glucose; Hyperglycemia; Insulin; Insulin Resistance; Myocytes, Cardiac; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Signal Transduction | 2008 |
Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Body Weight; Captopril; Cardiovascular Diseases; Drug Evaluation, Preclinical; Glucose; Heart; Insulin; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Myocardium; Obesity; Organ Culture Techniques; Organ Size; Oxygen Consumption; Signal Transduction | 2008 |
Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Glucose; Blood Pressure; Endothelins; Fructose; Hypertension; Imidazoles; In Vitro Techniques; Insulin; Insulin Resistance; Losartan; Male; Mesenteric Artery, Superior; Rats; Rats, Sprague-Dawley; Tetrazoles; Triglycerides; Vasoconstriction | 1995 |
Effects of angiotensin II on insulin sensitivity and fasting glucose metabolism in rats.
Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Fasting; Glucose; Insulin; Insulin Resistance; Male; Rats; Rats, Sprague-Dawley | 1994 |
Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension.
Topics: Adult; Angiotensin II; Blood Pressure; Female; Glucose; Glucose Clamp Technique; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Muscle, Smooth, Vascular; Obesity; Pressoreceptors; Sodium, Dietary | 1994 |
Impaired recovery of vascular smooth muscle intracellular calcium following agonist stimulation in insulin resistant (Zucker obese) rats.
Topics: Angiotensin II; Animals; Aorta; Arginine Vasopressin; Calcium; Calcium-Transporting ATPases; Cells, Cultured; Fluorometry; Fura-2; Hypertension; Insulin; Insulin Resistance; Male; Muscle, Smooth, Vascular; Obesity; Rats; Rats, Zucker; Sarcoplasmic Reticulum; Time Factors; Vasoconstriction; Vasodilation | 1993 |
Magnesium deficiency produces insulin resistance and increased thromboxane synthesis.
Topics: Aldosterone; Angiotensin II; Diet; Female; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin Resistance; Intracellular Membranes; Magnesium; Magnesium Deficiency; Male; Thromboxane A2 | 1993 |
Effects of losartan on insulin sensitivity in severe hypertension: connections through sympathetic nervous system activity?
Topics: Adult; Analysis of Variance; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Blood Glucose; Blood Viscosity; Glucose Clamp Technique; Humans; Hypertension; Imidazoles; Insulin Resistance; Losartan; Male; Sympathetic Nervous System; Tetrazoles | 1995 |
Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Body Weight; Cardiomegaly; Diet; Fructose; Glucose Tolerance Test; Hyperinsulinism; Imidazoles; Insulin; Insulin Resistance; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles | 1996 |
Renovascular hypertension and insulin sensitivity.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Case-Control Studies; Diuresis; Female; Humans; Hypertension, Renovascular; Insulin Resistance; Male; Middle Aged; Natriuresis; Renin; Renin-Angiotensin System | 1996 |
Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Fructose; Hypertension; Insulin Resistance; Male; Phenylephrine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1996 |
[The relationship between insulin resistance and angiotensin II and endothelins in patients with essential hypertension and coronary heart disease].
Topics: Adult; Aged; Angiotensin II; Blood Glucose; Coronary Disease; Endothelins; Female; Humans; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged | 1996 |
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria.
Topics: Adrenal Glands; Adult; Albuminuria; Angiotensin II; Blood Pressure; Body Weight; Diabetes Mellitus, Type 1; Diet; Diet, Sodium-Restricted; Female; Hemodynamics; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Natriuresis; Potassium; Renal Circulation; Sodium | 1998 |
Myocardial insulin resistance in cardiac hypertrophy.
Topics: Angiotensin II; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; Hypertrophy, Left Ventricular; Insulin; Insulin Resistance; Monosaccharide Transport Proteins; Muscle Proteins; Myocardium; Receptors, Angiotensin | 1999 |
[The study of mutation in exon 17 of insulin receptor gene in essential hypertensive pedigrees].
Topics: Adolescent; Angiotensin II; Blood Glucose; Exons; Female; Humans; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Point Mutation; Receptor, Insulin | 1997 |
Angiotensin II induces insulin resistance independent of changes in interstitial insulin.
Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Dogs; Extracellular Space; Femoral Artery; Glucose; Hyperinsulinism; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Inulin; Lymph; Male; Regional Blood Flow; Vascular Resistance; Vasoconstrictor Agents | 1999 |
Metformin treatment corrects vascular insulin resistance in hypertension.
Topics: Acetylcholine; Angiotensin II; Animals; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Nitric Oxide; Norepinephrine; Rats; Rats, Sprague-Dawley; Vasoconstriction | 2000 |
Possible interactions between angiotensin II and insulin: effects on glucose and lipid metabolism in vivo and in vitro.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Area Under Curve; Cell Line; Deoxyglucose; Dose-Response Relationship, Drug; Fructose; Glucose Tolerance Test; Imidazoles; Insulin; Insulin Antagonists; Insulin Resistance; Male; Muscles; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Triglycerides | 2000 |
Plasma levels of tumor necrosis factor-alpha, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance.
Topics: Adult; Angiotensin II; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Human Growth Hormone; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Leptin; Male; Middle Aged; Obesity; Risk Factors; Tumor Necrosis Factor-alpha | 2001 |
Effect of insulin and angiotensin II on cell calcium in human skin fibroblasts.
Topics: Adult; Angiotensin II; Calcium; Cells, Cultured; Culture Media; Cytosol; Female; Fibroblasts; Humans; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Pertussis Toxin; Skin; Thapsigargin; Virulence Factors, Bordetella | 2001 |
Left ventricular structure and diastolic function in subjects with two hypertensive parents.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Blood Pressure; Case-Control Studies; Catecholamines; Electrocardiography; Family Health; Female; Humans; Hypertension; Insulin Resistance; Male; Parents; Renin; Ventricular Dysfunction, Left; Ventricular Remodeling | 2001 |
Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cell Division; Cells, Cultured; Chromans; Depression, Chemical; DNA; Growth Substances; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Thiazoles; Thiazolidinediones; Troglitazone; Tyrosine | 2002 |
Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support.
Topics: Angiotensin II; Animals; Chlorisondamine; Diastole; Heart Rate; Hypertension; Insulin Resistance; Male; Norepinephrine; Obesity; Rats; Rats, Zucker; Sympathetic Nervous System; Systole | 1992 |
Insulin enhances pressor responses to norepinephrine in rat mesenteric vasculature.
Topics: Angiotensin II; Animals; Blood Pressure; Hyperinsulinism; Insulin; Insulin Resistance; Male; Mesenteric Arteries; Norepinephrine; Rats; Regional Blood Flow; Serotonin; Time Factors | 1992 |
Exogenous insulin augments in healthy volunteers the cardiovascular reactivity to noradrenaline but not to angiotensin II.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Drug Interactions; Humans; Insulin; Insulin Resistance; Male; Muscle, Smooth, Vascular; Norepinephrine; Renin | 1991 |